Results 271 to 280 of about 2,487,129 (382)

Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis

Arthritis &Rheumatology, EarlyView.
Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with their benefits and other unique characteristics, influence ...
Giovanni Adami, Kenneth G. Saag
wiley   +1 more source

Unveiling the role of the upper respiratory tract microbiome in susceptibility and severity to COVID-19. [PDF]

Front Cell Infect Microbiol
von Ameln Lovison O, Zempulski Volpato FC, Weber LG, Barth AL, Simon Coitinho A, Martins AF.   +5 more
europepmc   +1 more source

ANTlBIOTlC THERAPY OF SPECIFIC NON-TUBERCULOUS INFECTlOUS DISEASES OF THE LOWER RESPIRATORY TRACT [PDF]

, 1965
결괴플 기다려는, 환지 만연 진얀이 관 성히고, 심하 상태가   +2 more
openalex   +1 more source

Effect of High-Dose vs Standard-Dose Wintertime Vitamin D Supplementation on Viral Upper Respiratory Tract Infections in Young Healthy Children

Journal of the American Medical Association (JAMA), 2017
M. Aglipay, C. Birken, P. Parkin, M. Loeb, K. Thorpe, Yang Chen, A. Laupacis, M. Mamdani, C. Macarthur, J. Hoch, T. Mazzulli, J. Maguire   +11 more
semanticscholar   +1 more source

Time‐Dependent Effect of Prophylactic Trimethoprim‐Sulfamethoxazole on the Incidence of Serious Infections in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Target Trial Emulation Study

Arthritis &Rheumatology, EarlyView.
Objective The objective of this study was to investigate the effect of prophylactic trimethoprim‐sulfamethoxazole (TMP‐SMX) on the incidence of serious infections in patients with antineutrophil cytoplasmic antibody–associated vasculitis (AAV). Methods This multicenter cohort study was designed to emulate a target trial that studied 296 patients with ...
Yun Kyu Kim, Jeffrey R. Curtis, Se Rim Choi, Jina Yeo, Min Jung Kim, Yun Jong Lee, Eun Bong Lee, Jun Won Park   +7 more
wiley   +1 more source

Analysis of changes in respiratory tract infections in a tertiary grade A hospital in Zhangjiakou area from 2018 to 2024. [PDF]

Medicine (Baltimore)
Zhang L, Ma J, Qu S, Cui Z, Cao M.
europepmc   +1 more source

Burn Therapy II. The Revelation of Respiratory Tract Damage as a Principal Killer of the Burned Patient

, 1962
Anne Wight Phillips, Oliver Cope
openalex   +2 more sources

Probiotics for preventing acute upper respiratory tract infections

Cochrane Database of Systematic Reviews, 2015
Q. Hao, B. Dong, Taixiang Wu
semanticscholar   +1 more source

Hand Swelling and Other Non–Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts

Arthritis &Rheumatology, EarlyView.
Objective Raynaud phenomenon (RP) is often the initial clinical manifestation of systemic sclerosis (SSc), but some patients develop other manifestations first. To help elucidate the diversity of SSc presentation in its early stages, we describe the initial clinical manifestations and antinuclear antibody (ANA) profiles of patients in two early SSc ...
Iqtidar Hanif, Shervin Assassi, Maureen D. Mayes, Zsuzsanna H. McMahan, Meng Zhang, Julio Charles, John M. VanBuren, Jessica S. Alvey, Kimia Ghaffari, Elana J. Bernstein, Flavia V. Castelino, Lorinda Chung, Luke Evnin, Tracy M. Frech, Jessica K. Gordon, Faye N. Hant, Laura K. Hummers, Dinesh Khanna, Kimberly S. Lakin, Dorota Lebiedz‐Odrobina, Yiming Luo, Ashima Makol, Jerry A. Molitor, Duncan F. Moore, Carrie Richardson, Nora Sandorfi, Ami A. Shah, Ankoor Shah, Victoria K. Shanmugam, Virginia D. Steen, Elizabeth R. Volkmann, Carleigh Zahn, Brian Skaug   +32 more
wiley   +1 more source

<i>In Vitro</i> assessments of ENDS toxicity in the respiratory tract: Are we there yet? [PDF]

NAM J
Muthumalage T, Sarles E, Wang Q, Hensel E, Hill T, Rahman I, Robinson R, Stroup AM, Thongphanh K, Miller LA.   +9 more
europepmc   +1 more source